|
OmniMed (Pty) Ltd was founded in 1960 and its main activity was the manufacture of sterile intravenous solutions under license to a leading German manufacturer. The name of the Company at the time was Remedia Medical.
In time, the Company diversified into other forms of pharmaceutical manufacture but as it evolved, it embarked upon new ventures focusing on the hospital and specialist doctor market. It acquired new licenses offering a broad spectrum of hospital consumables and equipment.
Today OmniMed owes its diversity to its ability to adapt to changing markets. Due to its long-standing presence in the market, leading product portfolio and strong customer service, OmniMed is well known in both the Private and Public Health Care sectors.
Life-saving technologies, as well as products that improve the quality of life have always been the trademark of OmniMed.
OmniMed also provides administration and distribution services to BioMerieux SA a leading French Diagnostic company on a fee for service basis.
The manufacturing operation is located in Johannesburg and OmniMed has a fully owned well-established subsidiary in Namibia.
Mission Statement
Making it possible for the best products and service to reach people who care about quality and performance.
OmniMed markets and distributes a broad range of products across five operating divisions:
Summary of the group shareholders and directorships:
OmniMed Pty Ltd is owned by two privately held companies, Remedia Investments (Pty) Ltd 50%, B Hurwitz and Pule Medical Enterprises (Pty) Ltd 50% A Pulé.
Directorships:
A Pulé
B Hurwitz
G Wertheim Aymés
|